This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Side effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • bleeding - dose-related

  • in pregnancy, recommended that only used during the 13th to 36th week because of fetal abnormalities associated with it's use during the first trimester - chondrodysplasia punctata - and after the 36th week - fetal intracerebral bleeding. In instances where anticoagulation is indicated, it is recommended that low molecular weight heparin be used during the first trimester and after 36 weeks because it does not cross the placenta

  • in liver disease, there is a reduced requirement for warfarin because of reduced synthesis of clotting factors. Also if there is obstructive jaundice then there is a reduction in absorption of vitamin K, which in turn reduces the requirement for warfarin

  • in congestive heart failure, warfarin requirement is reduced

  • thyroid disease - requirements for warfarin are increased in thyrotoxicosis, and reduced in hypothyroidism

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.